ECAT (ECAT) Stock Price & Analysis
ECAT (ECAT) fell 0.59% to USD 15.05 as of July 25, 2026 at 01:46 UTC, according to Nexqual real-time market data.
ECAT last closed at USD 15.14; the session ranged USD 15.05–15.22 on volume of 462,613 shares. Market capitalization is $1.50B, with a 52-week range of USD 13.36–17.14 (NYQ). Source: Nexqual, July 25, 2026 at 01:46 UTC.
Key Statistics (as of July 25, 2026 at 01:46 UTC)
| Price | USD 15.05 |
|---|---|
| Change | ▼ 0.59% (down) |
| Previous Close | USD 15.14 |
| Open | USD 15.16 |
| Day Range | USD 15.05 – 15.22 |
| 52-Week Range | USD 13.36 – 17.14 |
| Volume | 462,613 shares |
| Market Cap | $1.50B |
| Exchange | NYQ |
Technical Analysis (ECAT)
Nexqual's technical model rates ECAT "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 01:46 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 35.26 (neutral) |
| vs SMA50 | Below (USD 15.48) |
| MACD | -0.06 (negative) |
Analyst Ratings (ECAT)
Wall Street analysts rate ECAT "None", per Nexqual as of July 25, 2026 at 01:46 UTC.
| Consensus Rating | None |
|---|
Earnings (ECAT)
Source: Nexqual, July 25, 2026 at 01:46 UTC.
Financials & Fundamentals (ECAT)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
Source: Nexqual, July 25, 2026 at 01:46 UTC.
Financial Health Score (ECAT)
Nexqual rates ECAT's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 01:46 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Ownership (ECAT)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +32.06% |
| Shares Outstanding | 99.47M |
| Short % of Float | +0.12% |
Source: Nexqual, July 25, 2026 at 01:46 UTC.
Leadership (ECAT)
ECAT is led by John M. Perlowski (age 61), President, CEO, CFO, Treasurer, Secretary & Trustee, per Nexqual as of July 25, 2026 at 01:46 UTC.
| President, CEO, CFO, Treasurer, Secretary & Trustee | John M. Perlowski (age 61) |
|---|
Major Backers & Investors (ECAT)
Notable institutional backers of ECAT include Saba Capital Management, L.P., Morgan Stanley, Invesco, according to Nexqual as of July 25, 2026 at 01:46 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Saba Capital Management, L.P. | 22.14% |
| Morgan Stanley | 2.22% |
| Invesco | 2.01% |
| Exchange Listed Funds Trust-Saba Closed-End Funds ETF | 1.87% |
| Cohen & Steers Inc. | 1.74% |
| Penserra Capital Management LLC | 1.47% |
| Amplify ETF Trust-Amplify CEF High Income ETF | 1.46% |
| Royal Bank of Canada | 1.23% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 1.24% |
Source: Nexqual, July 25, 2026 at 01:46 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BCAT | BlackRock Capital Allocation Term Trust | USD 15.31 | ▼ 2.17% |
| BMEZ | BlackRock Health Sciences Trust | USD 15.31 | ▲ 1.12% |
| WDI | Western Asset Diversified Income Fund | USD 13.12 | ▼ 2.67% |
| BSTZ | BlackRock Science and Technolog | USD 28.69 | ▼ 0.14% |
| NBXG | Neuberger Berman Income Funds - Neuberger Next Generation Connectivity Fund Inc. | USD 14.93 | ▼ 2.93% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:46 UTC. This page is informational and not investment advice.